{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:22:53Z","timestamp":1790425373412,"version":"4.1.0"},"reference-count":109,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,9,5]],"date-time":"2021-09-05T00:00:00Z","timestamp":1630800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R15AI150484"],"award-info":[{"award-number":["1R15AI150484"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Antibodies that can neutralize diverse HIV-1 strains develop in ~10\u201320% of HIV-1 infected individuals, and their elicitation is a goal of vaccine design. Such antibodies can also serve as therapeutics for those who have already been infected with the virus. Structural characterizations of broadly reactive antibodies in complex with the HIV-1 spike indicate that there are a limited number of sites of vulnerability on the spike. Analysis of their structures can help reveal commonalities that would be useful in vaccine design and provide insights on combinations of antibodies that can be used to minimize the incidence of viral resistance mutations. In this review, we give an update on recent structures determined of the spike in complex with broadly neutralizing antibodies in the context of all epitopes on the HIV-1 spike identified to date.<\/jats:p>","DOI":"10.3390\/v13091774","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T23:55:22Z","timestamp":1630972522000},"page":"1774","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2402-0984","authenticated-orcid":false,"given":"Emma","family":"Parker Miller","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, Swarthmore College, Swarthmore, PA 19081, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9039-4546","authenticated-orcid":false,"given":"Maxwell T.","family":"Finkelstein","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Swarthmore College, Swarthmore, PA 19081, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly C.","family":"Erdman","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Swarthmore College, Swarthmore, PA 19081, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Seth","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Swarthmore College, Swarthmore, PA 19081, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1706-9288","authenticated-orcid":false,"given":"Daniela","family":"Fera","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Swarthmore College, Swarthmore, PA 19081, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/imr.12506","article-title":"HIV Antibodies for Treatment of HIV Infection","volume":"275","author":"Margolis","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 Antibody 3BNC117 Suppresses Viral Rebound in Humans during Treatment Interruption","volume":"535","author":"Scheid","year":"2016","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"319ra206","DOI":"10.1126\/scitranslmed.aad5752","article-title":"Virologic Effects of Broadly Neutralizing Antibody VRC01 Administration during Chronic HIV-1 Infection","volume":"7","author":"Lynch","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia Suppressed in HIV-1-Infected Humans by Broadly Neutralizing Antibody 3BNC117","volume":"522","author":"Caskey","year":"2015","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12977-018-0455-9","article-title":"Antibody-Mediated Prevention and Treatment of HIV-1 Infection","volume":"15","author":"Gruell","year":"2018","journal-title":"Retrovirology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3389\/fimmu.2017.01590","article-title":"Non-Neutralizing Antibodies Directed against HIV and Their Functions","volume":"8","author":"Mayr","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"12655","DOI":"10.1038\/s41598-017-12883-6","article-title":"Non-Neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-Mediated Cytotoxic Activity","volume":"7","author":"Mayr","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7973652","article-title":"Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody","volume":"266","author":"Burton","year":"1994","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1128\/JVI.77.10.5863-5876.2003","article-title":"Molecular Features of the Broadly Neutralizing Immunoglobulin G1 B12 Required for Recognition of Human Immunodeficiency Virus Type 1 Gp120","volume":"77","author":"Zwick","year":"2003","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.32607\/20758251-2015-7-4-11-21","article-title":"Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response","volume":"7","author":"Shcherbakov","year":"2015","journal-title":"Acta Nat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.immuni.2018.04.029","article-title":"HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure","volume":"48","author":"Kwong","year":"2018","journal-title":"Immunity"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/imr.12484","article-title":"Identification and Specificity of Broadly Neutralizing Antibodies against HIV","volume":"275","author":"McCoy","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-immunol-041015-055515","article-title":"Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design","volume":"34","author":"Burton","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","article-title":"Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding","volume":"182","author":"Starr","year":"2020","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e65005","DOI":"10.7554\/eLife.65005","article-title":"Structure of HIV-1 Gp41 with Its Membrane Anchors Targeted by Neutralizing Antibodies","volume":"10","author":"Caillat","year":"2021","journal-title":"eLife"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.1016\/S0021-9258(18)86956-3","article-title":"Assignment of Intrachain Disulfide Bonds and Characterization of Potential Glycosylation Sites of the Type 1 Recombinant Human Immunodeficiency Virus Envelope Glycoprotein (Gp120) Expressed in Chinese Hamster Ovary Cells","volume":"265","author":"Leonard","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"15812","DOI":"10.1073\/pnas.2634931100","article-title":"Electron Tomography Analysis of Envelope Glycoprotein Trimers on HIV and Simian Immunodeficiency Virus Virions","volume":"100","author":"Zhu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0092-8674(88)90487-4","article-title":"Endoproteolytic Cleavage of Gp160 Is Required for the Activation of Human Immunodeficiency Virus","volume":"53","author":"McCune","year":"1988","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.2984774","article-title":"Characterization of Envelope and Core Structural Gene Products of HTLV-III with Sera from AIDS Patients","volume":"228","author":"Robey","year":"1985","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.3629244","article-title":"Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1","volume":"237","author":"Kowalski","year":"1987","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV Gp120 Envelope Glycoprotein in Complex with the CD4 Receptor and a Neutralizing Human Antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"14536","DOI":"10.1021\/jp9081239","article-title":"Understanding of the Bridging Sheet Formation of HIV-1 Glycoprotein Gp120","volume":"113","author":"Da","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03327","article-title":"Structure of an Unliganded Simian Immunodeficiency Virus Gp120 Core","volume":"433","author":"Chen","year":"2005","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nsmb.2711","article-title":"Prefusion Structure of Trimeric HIV-1 Envelope Glycoprotein Determined by Cryo-Electron Microscopy","volume":"20","author":"Bartesaghi","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.str.2014.08.010","article-title":"Capturing Glimpses of an Elusive HIV Gp41 Prehairpin Fusion Intermediate","volume":"22","author":"Tamm","year":"2014","journal-title":"Structure"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1479-5876-9-S1-S2","article-title":"HIV-1 Envelope, Integrins and Co-Receptor Use in Mucosal Transmission of HIV","volume":"9","author":"Cicala","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/1570162X113116660064","article-title":"HIV-1 Variable Loop 2 and Its Importance in HIV-1 Infection and Vaccine Development","volume":"11","author":"Rao","year":"2013","journal-title":"Curr. HIV Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nature01188","article-title":"HIV-1 Evades Antibody-Mediated Neutralization through Conformational Masking of Receptor-Binding Sites","volume":"420","author":"Kwong","year":"2002","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JVI.80.5.2515-2528.2006","article-title":"Nature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1","volume":"80","author":"Moore","year":"2006","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid Evolution of the Neutralizing Antibody Response to HIV Type 1 Infection","volume":"100","author":"Richman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/374124b0","article-title":"Recombination in HIV-1","volume":"374","author":"Robertson","year":"1995","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity Considerations in HIV-1 Vaccine Selection","volume":"296","author":"Gaschen","year":"2002","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1586\/14760584.7.9.1405","article-title":"Viral Sequence Diversity: Challenges for AIDS Vaccine Designs","volume":"7","author":"McBurney","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14954","DOI":"10.1038\/ncomms14954","article-title":"Global Site-Specific N-Glycosylation Analysis of HIV Envelope Glycoprotein","volume":"8","author":"Cao","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.immuni.2018.02.013","article-title":"A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope","volume":"48","author":"Zhou","year":"2018","journal-title":"Immunity"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody Neutralization and Escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.1128\/JVI.76.17.8875-8889.2002","article-title":"Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1","volume":"76","author":"Sanders","year":"2002","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sanders, R.W., Derking, R., Cupo, A., Julien, J.-P., Yasmeen, A., de Val, N., Kim, H.J., Blattner, C., de la Pe\u00f1a, A.T., and Korzun, J. (2013). A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 Gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003618"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/s41467-018-04272-y","article-title":"Structure of a Cleavage-Independent HIV Env Recapitulates the Glycoprotein Architecture of the Native Cleaved Trimer","volume":"9","author":"Sarkar","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2020.01.010","article-title":"Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody","volume":"180","author":"Schommers","year":"2020","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.chom.2020.03.024","article-title":"VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA","volume":"27","author":"Jia","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2020.12.014","article-title":"Vaccination Induces Maturation in a Mouse Model of Diverse Unmutated VRC01-Class Precursors to HIV-Neutralizing Antibodies with >50% Breadth","volume":"54","author":"Chen","year":"2021","journal-title":"Immunity"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"107488","DOI":"10.1016\/j.celrep.2020.03.052","article-title":"Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition","volume":"31","author":"Gorman","year":"2020","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"eabd2638","DOI":"10.1126\/science.abd2638","article-title":"Recapitulation of HIV-1 Env-Antibody Coevolution in Macaques Leading to Neutralization Breadth","volume":"371","author":"Roark","year":"2021","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Saunders, K.O., Wiehe, K., Tian, M., Acharya, P., Bradley, T., Alam, S.M., Go, E.P., Scearce, R., Sutherland, L., and Henderson, R. (2019). Targeted Selection of HIV-Specific Antibody Mutations by Engineering B Cell Maturation. Science, 366.","DOI":"10.1126\/science.aay7199"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kumar, S., Ju, B., Shapero, B., Lin, X., Ren, L., Zhang, L., Li, D., Zhou, Z., Feng, Y., and Sou, C. (2020). A V(H)1-69 Antibody Lineage from an Infected Chinese Donor Potently Neutralizes HIV-1 by Targeting the V3 Glycan Supersite. Sci. Adv., 6.","DOI":"10.1126\/sciadv.abb1328"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wang, Z., Barnes, C.O., Gautam, R., Cetrulo Lorenzi, J.C., Mayer, C.T., Oliveira, T.Y., Ramos, V., Cipolla, M., Gordon, K.M., and Gristick, H.B. (2020). A Broadly Neutralizing Macaque Monoclonal Antibody against the HIV-1 V3-Glycan Patch. eLife, 9.","DOI":"10.7554\/eLife.61991"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.immuni.2019.04.014","article-title":"Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope","volume":"50","author":"Schoofs","year":"2019","journal-title":"Immunity"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.immuni.2019.10.008","article-title":"Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability","volume":"51","author":"Dubrovskaya","year":"2019","journal-title":"Immunity"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature05580","article-title":"Structural Definition of a Conserved Neutralization Epitope on HIV-1 Gp120","volume":"445","author":"Zhou","year":"2007","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2016.04.010","article-title":"Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B and G","volume":"165","author":"Soto","year":"2016","journal-title":"Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cell.2015.05.007","article-title":"Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors","volume":"161","author":"Zhou","year":"2015","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","article-title":"Multi-Donor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for Effective HIV-1 Neutralization by VRCO1-Class Antibodies","volume":"39","author":"Zhou","year":"2013","journal-title":"Immunity"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1128\/JVI.00754-15","article-title":"The V1V2 Region of HIV-1 Gp120 Forms a Five-Stranded Beta Barrel","volume":"89","author":"Pan","year":"2015","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-Evolution of a Broadly Neutralizing HIV-1 Antibody and Founder Virus","volume":"496","author":"Liao","year":"2013","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nsmb.3144","article-title":"Structures of HIV-1 Env V1V2 with Broadly Neutralizing Antibodies Reveal Commonalities That Enable Vaccine Design","volume":"23","author":"Gorman","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature10696","article-title":"Structure of HIV-1 Gp120 V1\/V2 Domain with Broadly Neutralizing Antibody PG9","volume":"480","author":"McLellan","year":"2011","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1128\/JVI.00530-13","article-title":"Inhibition of the HIV-1 Spike by Single-PG9\/16-Antibody Binding Suggests a Coordinated-Activation Model for Its Three Protomeric Units","volume":"87","author":"Wu","year":"2013","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.immuni.2017.03.017","article-title":"A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic \u03b2-Hairpin Structure","volume":"46","author":"Lee","year":"2017","journal-title":"Immunity"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.immuni.2017.04.011","article-title":"Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody That Lacks a Protruding Loop","volume":"46","author":"Cale","year":"2017","journal-title":"Immunity"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"eaai7514","DOI":"10.1126\/scitranslmed.aai7514","article-title":"Staged Induction of HIV-1 Glycan\u2013Dependent Broadly Neutralizing Antibodies","volume":"9","author":"Bonsignori","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cell.2016.05.055","article-title":"HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant","volume":"166","author":"Simonich","year":"2016","journal-title":"Cell"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2016.06.026","article-title":"A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans","volume":"45","author":"Sok","year":"2016","journal-title":"Immunity"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad Neutralization Coverage of HIV by Multiple Highly Potent Antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41586-018-0804-9","article-title":"Structural Basis of Coreceptor Recognition by HIV-1 Envelope Spike","volume":"565","author":"Shaik","year":"2019","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"a006866","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: Cell Binding and Entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/bs.ai.2019.08.002","article-title":"Antibody Responses to the HIV-1 Envelope High Mannose Patch","volume":"143","author":"Daniels","year":"2019","journal-title":"Adv. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/14728222.2020.1752183","article-title":"Targeting the N332-Supersite of the HIV-1 Envelope for Vaccine Design","volume":"24","author":"Moyo","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","article-title":"Recent Progress in Broadly Neutralizing Antibodies to HIV","volume":"19","author":"Sok","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41467-018-03565-6","article-title":"HIV Envelope V3 Region Mimic Embodies Key Features of a Broadly Neutralizing Antibody Lineage Epitope","volume":"9","author":"Fera","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1128\/jvi.68.11.6836-6847.1994","article-title":"Immunological Evidence for Interactions between the First, Second, and Fifth Conserved Domains of the Gp120 Surface Glycoprotein of Human Immunodeficiency Virus Type 1","volume":"68","author":"Moore","year":"1994","journal-title":"J. Virol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.str.2020.04.022","article-title":"Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions","volume":"28","author":"Seabright","year":"2020","journal-title":"Structure"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"16199","DOI":"10.1038\/nmicrobiol.2016.199","article-title":"An HIV-1 Antibody from an Elite Neutralizer Implicates the Fusion Peptide as a Site of Vulnerability","volume":"2","author":"Ozorowski","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2014.04.008","article-title":"Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the Gp41\u2013Gp120 Interface on Intact HIV-1 Env Trimers","volume":"40","author":"Blattner","year":"2014","journal-title":"Immunity"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1038\/ncomms9167","article-title":"Antibodies to a Conformational Epitope on Gp41 Neutralize HIV-1 by Destabilizing the Env Spike","volume":"6","author":"Lee","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.celrep.2014.04.001","article-title":"Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike","volume":"7","author":"Scharf","year":"2014","journal-title":"Cell Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature13808","article-title":"Structure and Immune Recognition of Trimeric Prefusion HIV-1 Env","volume":"514","author":"Pancera","year":"2014","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.str.2018.10.007","article-title":"Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition","volume":"27","author":"Chuang","year":"2019","journal-title":"Structure"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1146\/annurev.biochem.70.1.777","article-title":"Mechanisms of Viral Membrane Fusion and Its Inhibition","volume":"70","author":"Eckert","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.aae0474","article-title":"Fusion Peptide of HIV-1 as a Site of Vulnerability to Neutralizing Antibody","volume":"352","author":"Kong","year":"2016","journal-title":"Science"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nsmb.1456","article-title":"Viral Membrane Fusion","volume":"15","author":"Harrison","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrm1076","article-title":"The Structural Biology of Type I Viral Membrane Fusion","volume":"4","author":"Colman","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41467-019-08825-7","article-title":"A Sequestered Fusion Peptide in the Structure of an HIV-1 Transmitted Founder Envelope Trimer","volume":"10","author":"Ananthaswamy","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/JVI.03136-14","article-title":"Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes","volume":"89","author":"Kong","year":"2015","journal-title":"J. Virol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"De la Pe\u00f1a, A.T., Rantalainen, K., Cottrell, C.A., Allen, J.D., van Gils, M.J., Torres, J.L., Crispin, M., Sanders, R.W., and Ward, A.B. (2019). Similarities and Differences between Native HIV-1 Envelope Glycoprotein Trimers and Stabilized Soluble Trimer Mimetics. PLoS Pathog., 15.","DOI":"10.1101\/500975"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.immuni.2015.12.001","article-title":"Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10","volume":"44","author":"Irimia","year":"2016","journal-title":"Immunity"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"eaal2200","DOI":"10.1126\/sciimmunol.aal2200","article-title":"Potent and Broad HIV-Neutralizing Antibodies in Memory B Cells and Plasma","volume":"2","author":"Williams","year":"2017","journal-title":"Sci. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.immuni.2004.12.011","article-title":"Broadly Neutralizing Anti-HIV Antibody 4E10 Recognizes a Helical Conformation of a Highly Conserved Fusion-Associated Motif in Gp41","volume":"22","author":"Cardoso","year":"2005","journal-title":"Immunity"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and Potent Neutralization of HIV-1 by a Gp41-Specific Human Antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1128\/JVI.78.19.10724-10737.2004","article-title":"Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its Gp41 Epitope","volume":"78","author":"Ofek","year":"2004","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2019.02.008","article-title":"Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual","volume":"50","author":"Krebs","year":"2019","journal-title":"Immunity"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chom.2019.09.016","article-title":"Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01","volume":"26","author":"Pinto","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1038\/s41467-019-12973-1","article-title":"An MPER Antibody Neutralizes HIV-1 Using Germline Features Shared among Donors","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1128\/JVI.00685-09","article-title":"A Conformational Switch in Human Immunodeficiency Virus Gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies","volume":"83","author":"Pejchal","year":"2009","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Morris, L., Chen, X., Alam, M., Tomaras, G., Zhang, R., Marshall, D.J., Chen, B., Parks, R., Foulger, A., and Jaeger, F. (2011). Isolation of a Human Anti-HIV Gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023532"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Caillat, C., Guilligay, D., Sulbaran, G., and Weissenhorn, W. (2020). Neutralizing Antibodies Targeting HIV-1 Gp41. Viruses, 12.","DOI":"10.3390\/v12111210"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"eabh2791","DOI":"10.1126\/sciadv.abh2791","article-title":"Disassembly of HIV Envelope Glycoprotein Trimer Immunogens Is Driven by Antibodies Elicited via Immunization","volume":"7","author":"Turner","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41591-018-0042-6","article-title":"Epitope-Based Vaccine Design Yields Fusion Peptide-Directed Antibodies That Neutralize Diverse Strains of HIV-1","volume":"24","author":"Xu","year":"2018","journal-title":"Nat. Med."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Dingens, A.S., Acharya, P., Haddox, H.K., Rawi, R., Xu, K., Chuang, G.-Y., Wei, H., Zhang, B., Mascola, J.R., and Carragher, B. (2018). Complete Functional Mapping of Infection- and Vaccine-Elicited Antibodies against the Fusion Peptide of HIV. PLoS Pathog., 14.","DOI":"10.1101\/307587"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature13036","article-title":"Developmental Pathway for Potent V1V2-Directed HIV-Neutralizing Antibodies","volume":"509","author":"Schramm","year":"2014","journal-title":"Nature"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","article-title":"Combination Therapy with Anti-HIV-1 Antibodies Maintains Viral Suppression","volume":"561","author":"Mendoza","year":"2018","journal-title":"Nature"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41591-018-0186-4","article-title":"Safety and Antiviral Activity of Combination HIV-1 Broadly Neutralizing Antibodies in Viremic Individuals","volume":"24","author":"Gruell","year":"2018","journal-title":"Nat. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-021-00285-9","article-title":"Immunofocusing and Enhancing Autologous Tier-2 HIV-1 Neutralization by Displaying Env Trimers on Two-Component Protein Nanoparticles","volume":"6","author":"Brouwer","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nano.2018.12.001","article-title":"Design and Characterization of a Self-Assembling Protein Nanoparticle Displaying HIV-1 Env V1V2 Loop in a Native-like Trimeric Conformation as Vaccine Antigen","volume":"16","author":"Karch","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1126\/science.aah3945","article-title":"Priming HIV-1 Broadly Neutralizing Antibody Precursors in Human Ig Loci Transgenic Mice","volume":"353","author":"Sok","year":"2016","journal-title":"Science"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.1038\/ncomms12041","article-title":"Presenting Native-like Trimeric HIV-1 Antigens with Self-Assembling Nanoparticles","volume":"7","author":"He","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.aac5894","article-title":"Priming a Broadly Neutralizing Antibody Response to HIV-1 Using a Germline-Targeting Immunogen","volume":"349","author":"Jardine","year":"2015","journal-title":"Science"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors","volume":"340","author":"Jardine","year":"2013","journal-title":"Science"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/9\/1774\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:56:55Z","timestamp":1760165815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/9\/1774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,5]]},"references-count":109,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["v13091774"],"URL":"https:\/\/doi.org\/10.3390\/v13091774","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,5]]}}}